natgillin/translations-raw huggingface dataset:
Therefore, prescribers should take into account the most recent information available on oseltamivir susceptibility patterns of the currently circulating viruses when deciding whether to use Tamiflu. 
Zato morajo zdravniki pri predpisovanju zdravila Tamiflu upoštevati najnovejše razpoložljive informacije o občutljivosti vzorcev trenutno krožečega virusa na oseltamivir.
• Two small bowls (use separate pairs of bowls for each child) 
(za vsakega otroka uporabljajte ločen par posod),
Transfer the suspension to an amber glass or amber polyethyleneterephthalate (PET) bottle. 
Suspenzijo prenesite v steklenico iz jantarjevega stekla ali plastenko iz jantarjevega polietilentereftalata (PET).
Close the bottle tightly with the cap (on the top of the bottle adapter). 
S pokrovčkom tesno zaprite steklenico (na vrh nastavka za steklenico).
Infants less than 1 year of age: The pharmacokinetics, pharmacodynamics and safety of Tamiflu have been evaluated in two uncontrolled open-label studies including influenza infected children less than one year of age (n=135). 
Dojenčki, mlajši od 1 leta: farmakokinetika, farmakodinamika in varnost zdravila Tamiflu je bila ovrednotena v dveh odprtih kliničnih študijah brez kontrolne skupine, ki sta vključevali z gripo okužene otroke, mlajše od 1 leta (n = 135).
In patients with influenza who were receiving Tamiflu, there have been postmarketing reports of convulsions and delirium (including symptoms such as altered level of consciousness, confusion, abnormal behaviour, delusions, hallucinations, agitation, anxiety, nightmares), in a very few cases resulting in self-injury or fatal outcomes. 
Pri bolnikih z gripo, ki so prejemali zdravilo Tamiflu, so po prihodu zdravila na trg poročali o konvulzijah in deliriju (vključno s simptomi, kot so spremenjena raven zavesti, zmedenost, nenavadno vedenje, prividi, halucinacije, agitacija, aksioznost, more), ki je v zelo redkih primerih vodil do samopoškodbe ali smrti.
• Tamiflu can also be prescribed for adults, adolescents, children and infants above 1 year of age for preventing flu, on a case-by-case basis - for instance, if you have been in contact with someone who has flu. 
· Zdravilo Tamiflu se lahko predpiše odraslim, mladostnikom, otrokom in dojenčkom, starejšim od 1 leta, tudi za preprečevanje gripe, odvisno od primera do primera - na primer, če ste bili v stiku z osebo, ki ima gripo.
Slowly pull out the plunger to draw medicine into the dispenser. 
Počasi izvlecite bat, da odvzamete zdravilo v odmernik.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 20 June 2002 
Datum prve odobritve: 20. junij 2002 Datum zadnjega podaljšanja: 22. maj 2012
Tamiflu is indicated in adults and children including full term neonates who present with symptoms typical of influenza, when influenza virus is circulating in the community. 
Zdravilo Tamiflu je indicirano pri odraslih in otrocih, vključno z donošenimi novorojenčki, ki imajo simptome, značilne za gripo, ko je virus influence prisoten v okolici.
Titanium dioxide (E171) FD and C Blue 2 (indigo carmine, E132) 
Tiskarsko črnilo šelak titanov dioksid (E171) FD in C modro 2 (indigo karmin, E132)
In a double blind study for the treatment of influenza, a total of 199 adult immunocompromised patients (evaluable for safety) were randomized to receive Tamiflu for 10 days: 98 patients received the standard dose (75 mg twice daily) and 101 patients received the double dose (150 mg twice daily). 
V dvojno slepi študiji zdravljenja gripe so skupno randomizirali 199 odraslih imunsko ogroženih bolnikov (ocenljivih glede varnosti), ki so prejemali zdravilo Tamiflu 10 dni: 98 bolnikov je prejemalo običajni odmerek (75 mg dvakrat na dan), 101 bolnik pa je prejemal dvojni odmerek (150 mg dvakrat na dan).
Tamiflu hard capsules and Tamiflu suspension are bioequivalent formulations. 
Trde kapsule zdravila Tamiflu in suspenzija zdravila Tamiflu sta bioekvivalentni obliki.
Doses of 2 mg/kg give oseltamivir carboxylate exposures comparable to those achieved in adults receiving a single 75 mg dose (approximately 1 mg/kg). 
Pri odmerku 2 mg/kg je izpostavljenost oseltamivir karboksilatu primerljiva z izpostavljenostjo, ki jo dosežemo pri odraslih, ki prejmejo enkratni odmerek 75 mg (približno 1 mg/kg).
In addition, 199 immunocompromised adult patients received Tamiflu for the treatment of influenza and 475 immunocompromised patients (including 18 children, of these 10 Tamiflu and 8 placebo) received Tamiflu or placebo for the prophylaxis of influenza. 
Poleg tega je 199 odraslih imunsko ogroženih bolnikov prejemalo zdravilo Tamiflu za zdravljenje gripe in 475 imunsko ogroženih bolnikov (vključno z 18 otroki, od tega jih je 10 prejemalo zdravilo Tamiflu in 8 placebo) prejemalo zdravilo Tamiflu ali placebo za preprečevanje gripe.
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal. 
· Redno posodobljena poročila o varnosti zdravila (PSUR) Zahteve glede predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7)
Titanium dioxide (E171) 
titanov dioksid (E171)
• Skin reactions (inflammation of the skin, red and itchy rash, scaling skin). 
· kožne reakcije (vnetje kože, rdeč in srbeč izpuščaj, luščenje kože).
See the first set of instructions. 
Glejte prvi del navodil.
After reconstitution with 55 ml of water, the usable volume of oral suspension allows for the retrieval of a total of 10 doses of 30 mg oseltamivir. 
Po rekonstituciji s 55 ml vode je uporaben volumen peroralne suspenzije za 10 odmerkov po 30 mg oseltamivirja.
• Close the bottle, keep it safe Put the cap back on the bottle. 
· Zaprite steklenico in jo shranite na varno Zaporko pritrdite nazaj na steklenico.
It is recommended that Tamiflu powder for oral suspension be constituted by a pharmacist prior to dispensing to the patient (see section 6.6). 
Priporočljivo je, da peroralno suspenzijo zdravila Tamiflu pripravi farmacevt, preden zdravilo izda bolniku (glejte poglavje 6.6).
Measure 55 ml of water by filling the measuring cup to the indicated level (measuring cup included in the box). 
Odmerite 55 ml vode, tako da jo napolnite v merilno čašo do označenega nivoja (merilna čaša je priložena v škatli).
Infants (<1year) * Full genotyping was not performed in all studies. 
odrasli in mladostniki otroci (1-12 let) dojenčki (< 1 leto) * Popolne genotipizacije v vseh študijah niso izvedli.
Based on preclinical data, there is no evidence that Tamiflu has an effect on male or female fertility (see section 5.3). 
Glede na predklinične podatke, ni dokazov, da bi zdravilo Tamiflu vplivalo na plodnost moških ali žensk (glejte poglavje 5.3).
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT The volume of the reconstituted suspension is 65 ml 1 ml contains 6 mg oseltamivir 
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT Volumen rekonstituirane suspenzije je 65 ml 1 ml vsebuje 6 mg oseltamivirja
Then turn the whole unit upside down (bottle and dispenser together). 
Vse skupaj (steklenico in odmernik) obrnite od zgoraj navzdol.
Check the cap is secure, and then shake the bottle of Tamiflu oral suspension. 
Preverite, da je zaporka pritrjena in nato pretresite steklenico peroralne suspenzije zdravila Tamiflu.
Shake the bottle well for 15 seconds. 
Steklenico ponovno zaprite z zaporko in dobro stresajte 15 sekund.
In pre- and post-natal rat studies, prolonged parturition was noted at 1,500 mg/kg/day: the safety margin between human exposure and the highest no-effect dose (500 mg/kg/day) in rats is 480-fold for oseltamivir and 44-fold for the active metabolite, respectively. 
V pre- in postnatalnih študijah pri podganah so pri odmerku 1500 mg/kg/dan opazili podaljšan porod: varnostno razmerje med izpostavljenostjo pri ljudeh in največjim odmerkom, ki ni povzročil omenjenega neželenega učinka (500 mg/kg/dan) pri podganah, je 480-krat večje za oseltamivir in 44krat večje za aktivni presnovek.
This procedure describes the preparation of a 6 mg/ml suspension that will provide one patient with enough medication for a 5-day course of treatment or a 10-day course of prophylaxis. 
Postopek opisuje pripravo 6 mg/ml suspenzije, ki enemu bolniku zadošča za 5-dnevni potek zdravljenja ali 10-dnevni potek preprečevanja bolezni.
Tamiflu is not a substitute for influenza vaccination. 
Zdravilo Tamiflu ni nadomestilo cepljenja proti gripi.
Safety information available on oseltamivir administered for treatment of influenza in infants less than one year of age from prospective and retrospective observational studies (comprising together more than 2,400 infants of that age class), epidemiological databases research and postmarketing reports suggest that the safety profile in infants less than one year of age is similar to the established safety profile of children aged one year and older. 
Razpoložljive informacije o varnosti oseltamivirja za zdravljenje gripe pri dojenčkih, mlajših od enega leta, iz prospektivnih in retrospektivnih opazovalnih študij (ki vključujejo skupaj več kot 2400 dojenčkov tega starostnega razreda), podatkovne baze epidemioloških raziskav in poročil, pridobljenih v obdobju trženja, kažejo, da je varnostni profil pri dojenčkih, mlajših od enega leta, podoben znanemu varnostnemu profilu pri otrocih, starih eno leto in več.
When only 75 mg capsules are available, and doses of 30 mg or 45 mg are needed, the preparation of Tamiflu suspension involves additional steps. 
Kadar so na voljo le 75-mg kapsule in potrebujemo 30-mg ali 45-mg odmerek, so v postopku priprave suspenzije zdravila Tamiflu potrebni dodatni koraki.
A rat fertility study up to a dose of 1,500 mg/kg/day demonstrated no adverse reactions on either sex. 
Študija plodnosti pri podganah, ki so prejemale odmerke do 1500 mg/kg/dan, ni pokazala neželenih učinkov pri nobenem spolu.
What you need to know before you take Tamiflu 
Kaj morate vedeti, preden boste vzeli zdravilo Tamiflu
What Tamiflu looks like and contents of the pack 
Izgled zdravila Tamiflu in vsebina pakiranja
Insufficient data are available for infants who have a post-conceptual age of less than 36 weeks. 
Na voljo ni dovolj podatkov za dojenčke s postkoncepcijsko starostjo manj kot 36 tednov.
In a 12-week prophylaxis study in 475 immunocompromised patients, including 18 children 1 to 12 years of age and older, the safety profile in the 238 patients who received oseltamivir was consistent with that previously observed in Tamiflu prophylaxis clinical studies. 
V 12-tedenski študiji preprečevanja gripe pri 475 imunsko ogroženih bolnikih, vključno z 18 otroki, starimi od 1 do 12 let in več, je bil varnostni profil pri 238 bolnikih, ki so prejemali oseltamivir, v skladu s tistim, ki so ga predhodno ugotovili v kliničnih študijah preprečevanja gripe z zdravilom Tamiflu.
• Upset stomach. 
• vzdražen želodec.
Of the older subjects, 64 % were influenza-positive and of those with chronic cardiac and/or respiratory disease 62 % were influenza-positive. 
Med starejšimi bolniki je bilo z virusom influence okuženih 64 %, med bolniki s kronično boleznijo srca ali boleznijo dihal ali obojim pa jih je bilo z virusom influence okuženih 62 %.
Tamiflu 30 mg, 45 mg and 75 mg capsules and oral suspension are available for infants and children 1 year of age or older 
Kapsule zdravila Tamiflu 30 mg, 45 mg in 75 mg in peroralna suspenzija so na voljo za dojenčke in otroke, stare 1 leto ali več.
Read the package leaflet before use For oral use after reconstitution Shake bottle well before use Caution: dispenser graduated in millilitre (ml) 
Pred uporabo preberite priloženo navodilo Za peroralno uporabo po pripravi suspenzije Pred uporabo steklenico dobro pretresite Pozor: peroralni odmernik ima merilno skalo v mililitrih (ml)
Tamiflu 6 mg/ml powder for oral suspension is available in a bottle containing 13 g powder for mixing with 55 ml of water. 
Prašek za peroralno suspenzijo zdravila Tamiflu 6 mg/ml je na voljo v steklenici, ki vsebuje 13 g praška za mešanje z 55 ml vode.
Overdose has been reported to have occurred more frequently when Tamiflu was given to children than to adults and adolescents. 
Poročali so, da je do prevelikega odmerjanja prišlo pogosteje, kadar so zdravilo Tamiflu prejeli otroci, kot pa odrasli in mladostniki.
Do not take Tamiflu. 
Ne vzemite zdravila Tamiflu.
METHOD AND ROUTE(S) OF ADMINISTRATION Read package leaflet before use Oral use 
POSTOPEK IN POT(I) UPORABE ZDRAVILA Pred uporabo preberite priloženo navodilo za peroralno uporabo
Decisions regarding the use of oseltamivir for treatment and prophylaxis should take into consideration what is known about the characteristics of the circulating influenza viruses, available information on influenza drug susceptibility patterns for each season and the impact of the disease in different geographical areas and patient populations (see section 5.1). 
Pri odločitvi glede uporabe oseltamivirja za zdravljenje in preprečevanje je treba upoštevati vse, kar je znanega o značilnostih krožečih virusov gripe, razpoložljive informacije za vsako sezono o občutljivosti vzorcev na zdravilo proti gripi in vpliv bolezni na različnih geografskih območjih in na različne skupine bolnikov (glejte poglavje 5.1).
This is suitable for younger children and babies: they usually need a Tamiflu dose of less than 30 mg. See the lower set of instructions. 
Takšna priprava je primerna za mlajše otroke in dojenčke: ponavadi potrebujejo odmerke zdravila Tamiflu, ki so manjši od 30 mg. Glejte spodnji del navodil.
Prevention of influenza - Post-exposure prevention in individuals 1 year of age or older following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community. 
· Preventiva po predhodni izpostavljenosti virusu pri posameznikih, starih 1 leto ali več, ki so bili v stiku s klinično diagnosticirano gripo, ko je virus influence razširjen v okolici.
METHOD OF ADMINISTRATION For oral use after reconstitution Shake bottle well before use 
POSTOPEK UPORABE Za peroralno uporabo po pripravi suspenzije Pred uporabo steklenico dobro pretresite
Do not use 30 mg capsules 
Ne uporabljajte 30-mg kapsul
• Tamiflu may be prescribed for adults, adolescents, children and infant (including full-term newborn babies) as preventive treatment in exceptional circumstances - for example, if there is a global epidemic of flu (a flu pandemic) and the seasonal flu vaccine may not provide sufficient protection. 
· Zdravilo Tamiflu se lahko predpiše odraslim, mladostnikom, otrokom in dojenčkom (vključno z donošenimi novorojenčki) za preventivno zdravljenje v izjemnih okoliščinah - na primer v primeru globalne epidemije gripe (pandemija gripe) in ko cepljenje proti sezonski gripi ne omogoča zadostne zaščite.
100 ml amber glass bottle (with child-resistant polypropylene screw cap, outer part: polyethylene; inner part: polypropylene; liner: polyethylene) with 13 g of powder for oral suspension, a plastic adapter (low density polyethylene) , plastic 3 ml oral dispenser (0.1 ml graduation) and 10 ml oral dispenser (0.5 ml graduation) (barrel and plunger: polypropylene, silicon based seal ring) and a plastic measuring cup (polypropylene). 
100-ml steklenica iz jantarjevega stekla (z za otroke varno polipropilensko zaporko z navojem, zunanji del: polietilen, notranji del: polipropilen, obloga: polietilen) s 13 g praška za peroralno suspenzijo, plastični nastavek (polietilen nizke gostote), plastični 3-ml peroralni odmernik (skala po 0,1 ml) in 10ml peroralni odmernik (skala po 0,5 ml) (brizga in bat: polipropilen, tesnilo na osnovi silikona) in plastično merilno čašo (polipropilen).
Immunocompromised Patients 
Imunsko ogroženi bolniki
Tamiflu contains oseltamivir, which belongs to a group of medicines named neuraminidase inhibitors. 
Zdravilo Tamiflu vsebuje oseltamivir, ki spada v skupino zdravil, ki jih imenujemo zaviralci nevraminidaze.
Treating flu: dose for 5 days 
Zdravljenje gripe: odmerjanje za 5 dni
Adults, adolescents 13 years and over, and children weighing 40 kg and over 
Odrasli, mladostniki, stari 13 let in več, in otroci s telesno maso 40 kg in več
(Note: The drug substance, oseltamivir phosphate, readily dissolves in water. 
(Opomba: učinkovina oseltamivirjev fosfat se takoj raztopi v vodi.
• Tap the bottle to loosen the powder Tap the closed bottle gently several times to loosen the powder. 
· Potrkajte na steklenico, da se prašek zrahlja Na zaprto steklenico večkrat rahlo potrkajte, da se prašek zrahlja.
It is recommended that Tamiflu oral suspension should be reconstituted by the pharmacist prior to being dispensed to the patient. 
Priporočljivo je, da peroralno suspenzijo zdravila Tamiflu pripravi farmacevt, preden jo izda bolniku.
The ARs listed in the tables below fall into the following categories: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), and very rare (< 1/10,000). 
zelo pogosti (³ 1/10), pogosti (³ 1/100 do < 1/10), občasni (³ 1/1000 do < 1/100), redki (³ 1/10.000
Each ml of suspension contains 6 mg oseltamivir. 
En ml suspenzije vsebuje 6 mg oseltamivirja.
A total of 158 children received the recommended dose of Tamiflu once daily in a post-exposure prophylaxis study in households (n = 99), a 6-week paediatric seasonal prophylaxis study (n = 49) and a 12-week paediatric seasonal prophylaxis study in immunocompromised subjects (n = 10). 
Skupno 158 otrok je prejelo priporočeni odmerek zdravila Tamiflu enkrat na dan v študiji preprečevanja po izpostavitvi v gospodinjstvu (n = 99), v 6-tedenski pediatrični študiji preprečevanja sezonske gripe (n = 49) in v 12-tedenski pediatrični študiji preprečevanja sezonske gripe pri imunsko ogroženih bolnikih (n = 10).
Screw the cap tightly onto the top of the bottle, which now includes the adapter. 
Močno privijte zaporko na vrh steklenice, ki ima sedaj nameščen nastavek za steklenico.
Table 2 Adverse reactions in studies investigating Tamiflu for treatment and prevention of influenza in children (age/weight-based dosing [30 mg to 75 mg o.d.]) 
Preglednica 2 Neželeni učinki v študijah, ki so preučevale zdravljenje in preprečevanje gripe pri otrocih z zdravilom Tamiflu (odmerjanje glede na starost/telesno maso [30 mg do 75 mg enkrat na dan])
Prevention of influenza: Dose adjustment is recommended for adults and adolescents (13 to 17 years of age) with moderate or severe renal impairment as detailed in the table below. 
Preprečevanje gripe: prilagajanje odmerkov je priporočljivo za odrasle in mladostnike (stare od 13 do 17 let) z zmerno ali hudo ledvično okvaro, kot je opisano v spodnji preglednici.
Do not use 45 mg capsules 
Ne uporabljajte 45-mg kapsul
The most frequently (very common and common) reported side effects of Tamiflu are feeling or being sick (nausea, vomiting), stomach ache, stomach upset, headache and pain. 
Neželeni učinki zdravila Tamiflu, o katerih so najpogosteje (zelo pogosto in pogosto) poročali, so slabo počutje (siljenje na bruhanje, bruhanje), bolečina v želodcu, razdražen želodec, glavobol in bolečina.
The MAH shall ensure that at the launch of Tamiflu 6 mg/ml powder for oral suspension, all physicians who are expected to prescribe or use Tamiflu are provided with a Direct Healthcare Professional Communication letter, the text of which is appended to the CHMP assessment report. 
Imetnik dovoljenja za promet z zdravilom mora pred prihodom zdravila Tamiflu 6 mg/ml praška za peroralno suspenzijo na trg zagotoviti, da bodo vsi zdravniki, za katere se pričakuje, da bodo predpisovali zdravilo Tamiflu, prejeli Neposredno obvestilo za zdravstvene delavce (Direct Healthcare Professional Communication letter - DHPC) z vsebino, ki je priložena poročilu CHMP.
If the commercially manufactured Tamiflu oral suspension and the pharmacy compounded suspension is also not available, Tamiflu suspension may be prepared at home. 
Če komercialno izdelane peroralne suspenzije zdravila Tamiflu in tudi suspenzije, pripravljene v lekarni, ni na voljo, se lahko suspenzija zdravila Tamiflu pripravi doma.
This is suitable for younger, lighter children and babies: they usually need a Tamiflu dose of less than 45 mg. See the lower set of instructions. 
Takšna priprava je primerna za mlajše otroke in dojenčke: ponavadi potrebujejo odmerke zdravila Tamiflu, ki so manjši od 45 mg. Glejte spodnji del navodil.
There has been no evidence for emergence of drug resistance associated with the use of Tamiflu in clinical studies conducted to date in post-exposure (7 days), post-exposure within household groups (10 days) and seasonal (42 days) prevention of influenza in immunocompetent patients. 
Dokazov za pojav odpornosti na zdravilo zaradi uporabe zdravila Tamiflu v do sedaj izvedenih kliničnih študijah preprečevanja gripe po predhodni izpostavljenosti virusu (7 dni), po predhodni izpostavljenosti virusu med skupino v gospodinjstvu (10 dni) in pri sezonskih študijah (42 dni), pri bolnikih, katerih imunski odziv je normalen, ni bilo.
Post-exposure prevention 
Preprečevanje Preprečevanje po izpostavljenosti virusu
Infants less than 1 year 
Dojenčki, stari manj kot 1 leto
You will need to prepare a dose of less than 75 mg for children who weigh less than 40 kg. See below. 
Neprimerno za otroke, ki tehtajo manj kot 40 kg Za otroke s telesno maso nižjo od 40 kg, morate pripraviti odmerke, nižje od 75 mg. Glejte spodaj.
Infants less than 1 year, and children weighing less than 40 kg 
Dojenčki, mlajši od 1 leta, in otroci s telesno maso manj kot 40 kg
Adults, and adolescents 13 years and over 
Odrasli in mladostniki, stari 13 let in več
The pharmacist may compound a 6 mg/ml suspension from Tamiflu 30 mg, 45 mg or 75 mg capsules using water containing 0.05 % w/v sodium benzoate added as a preservative. 
Farmacevt lahko pripravi 6 mg/ml suspenzijo iz Tamiflu 30 mg, 45 mg ali 75 mg kapsul s pomočjo vode, ki vsebuje 0,05 % m/v natrijevega benzoata kot konzervans.
Infants and children 1 year of age or older: The pharmacokinetics of oseltamivir have been evaluated in single-dose pharmacokinetic studies in infants, children and adolescents 1 to 16 years of age. 
Dojenčki in otroci, stari 1 leto ali več: farmakokinetiko oseltamivirja pri dojenčkih, otrocih in mladostnikih, starih od 1 do 16 let, so raziskovali v študiji farmakokinetike enkratnih odmerkov.
When commercially manufactured Tamiflu oral suspension is not available, a pharmacy compounded suspension prepared from Tamiflu capsules must be used (see detailed instructions above). 
Kadar komercialno izdelane peroralne suspenzije zdravila Tamiflu ni na voljo, je treba uporabiti suspenzijo, pripravljeno v lekarni iz Tamiflu kapsul (glejte podrobna navodila zgoraj).
Also contains 1 plastic bottle adapter, 1 plastic measuring cup (55 ml), 1 plastic 3 ml oral dispenser and 1 plastic 10 ml oral dispenser. 
Vsebuje tudi 1 plastični nastavek za steklenico, 1 plastično merilno čašo (55 ml), 1 plastični 3-ml peroralni odmernik in 1 plastični 10-ml peroralni odmernik
Detailed information on the home preparation can be found in the package leaflet of Tamiflu capsules under “Making liquid Tamiflu at home”. 
Podrobne informacije glede priprave doma lahko najdete v Navodilu za uporabo zdravila Tamiflu kapsule pod naslovom ''Priprava tekočega zdravila Tamiflu doma''.
Detailed instructions can be found in the package leaflet of Tamiflu capsules under “Making liquid Tamiflu at home”. 
Podrobna navodila lahko najdete v Navodilu za uporabo Tamiflu kapsul pod naslovom ''Priprava tekočega zdravila Tamiflu doma''.
SPECIAL STORAGE CONDITIONS Do not store above 25 °C 
POSEBNA NAVODILA ZA SHRANJEVANJE Shranjujte pri temperaturi do 25 °C
The dose is the same for treating or preventing flu. 
Odmerek za zdravljenje ali preprečevanje gripe je enak.
• Angioneurotic oedema: sudden onset of severe swelling of the skin mainly around the head and neck area, including eyes and tongue, with difficulties breathing 
· angionevrotični edem: nenaden pojav hudega otekanja kože v glavnem okoli glave in vratu,